remazolam

Phase 1Small molecule

SSichuan Provincial People's Hospital

remazolam is one of 58 small molecule programs targeting Delirium. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DeliriumActive, not recruiting

AnesthesiaNot yet recruiting

DeliriumPreclinical

Active, not recruiting

AnesthesiaPhase 1

Not yet recruiting

Competition

Competitive Landscape

78 competitors in Delirium

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

58 2

Haldol

DDePuy Orthopaedics

Approved

21 3

Exelon

Novartis

Approved

6 4

Seroquel

EEngelhard Arzneimittel GmbH & Co.KG

Approved

10 5

Voltaren

Novartis

Approved

1 6

Aleve

Jazz Pharmaceuticals

Approved

1 7

Duragesic

CCephalon

Approved

7 8

Anerem

AAcacia Pharma Ltd

Approved

5 9

Spravato

WWim Janssens

Approved

4 10

Tylenol

KKenvue Brands

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Anesthesia1 trial

Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery

Not yet recruiting·SSichuan Provincial People's Hospital·Phase 1·NCT06205719·93 enrolled

Delirium1 trial

The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients

Completed·FFang Jun·N/A·NCT05466279·131 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for remazolam. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — remazolam compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for remazolam. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sichuan Provincial People's Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: SSichuan Provincial People's Hospital

remazolam

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Anesthesia1 trial

Delirium1 trial

References

Drug Info

Quick Facts

Related News